Literature DB >> 16155145

Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients.

Robert J Young1, Munir V Ghesani, Nolan J Kagetsu, Andrew J Derogatis.   

Abstract

BACKGROUND AND
PURPOSE: Discrimination between enhancing mass lesions in acquired immunodeficiency syndrome (AIDS) patients with conventional CT and MR imaging remains difficult. We determined the effect of lesion size on thallium-201 brain single-photon emission tomography (SPECT) imaging in differentiating primary brain lymphoma from cerebral toxoplasmosis.
METHODS: We retrospectively identified 35 AIDS patients with a total of 48 focal enhancing mass lesions on contrast-enhanced brain CT and/or MR images who subsequently underwent thallium-201 brain SPECT imaging. The thallium index of each lesion was evaluated on the basis of the ratio of mean uptake in the lesion compared with the corresponding contralateral side. Receiver operator curves were drawn to determine the optimal thallium index threshold. The effect of lesion size on scan accuracy was evaluated.
RESULTS: Malignant lesions in 20 patients had a mean thallium index of 2.4 (range, 1-11). Infectious lesions in 15 patients had a mean thallium index of 1.6 (range, 1-3.6). Twenty-five lesions were <2 cm (14 malignant, 11 nonmalignant) and 23 lesions were > or =2 cm (14 malignant, 9 nonmalignant). Thallium index was not a significant predictor of malignancy in the lesions <2 cm by using the logistic regression (P = .27). Receiver operator curve analysis by using thallium index of 2 in small lesions yielded 50% sensitivity and 82% specificity. In contrast, thallium index was a significant predictor of malignancy in lesions > or =2 cm (P < .01), yielding 100% sensitivity and 89% specificity.
CONCLUSION: Lesion size is a significant determinant of the accuracy of thallium-201 brain SPECT imaging, which should be the initial diagnostic tool for lesions > or =2 cm.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155145      PMCID: PMC8148819     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

1.  Radiologic-pathologic correlation. Cerebral toxoplasmosis and lymphoma in AIDS.

Authors:  L Chang; M E Cornford; F L Chiang; T M Ernst; N C Sun; B L Miller
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

2.  False-negative single-photon emission CT in AIDS lymphoma: lack of effect of steroids.

Authors:  B G Campbell; J Hurley; R D Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

3.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.

Authors:  R F Miller; M A Hall-Craggs; D C Costa; N S Brink; F Scaravilli; S B Lucas; I D Wilkinson; P J Ell; B E Kendall; M J Harrison
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

4.  Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.

Authors:  A D'Amico; C Messa; A Castagna; F Zito; L Galli; G Pepe; A Lazzarin; G Lucignani; F Fazio
Journal:  Nucl Med Commun       Date:  1997-08       Impact factor: 1.690

5.  Cerebral lymphoma in AIDS. Clinical, radiological, neuropathological and immunopathological study.

Authors:  J R Iglesias-Rozas; B Bantz; T Adler; G Jautzke; U Tosth; W Lange; H Stein; D Dienemann
Journal:  Clin Neuropathol       Date:  1991 Mar-Apr       Impact factor: 1.368

6.  Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

Authors:  A Antinori; A Ammassari; A De Luca; A Cingolani; R Murri; G Scoppettuolo; M Fortini; T Tartaglione; L M Larocca; G Zannoni; P Cattani; R Grillo; R Roselli; M Iacoangeli; M Scerrati; L Ortona
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

Review 7.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

8.  [Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions].

Authors:  I Berry; J F Gaillard; Z Guo; Y S Cordoliani; P Massip; C Manelfe; B Danet
Journal:  J Neuroradiol       Date:  1995-09       Impact factor: 3.447

9.  Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

Authors:  B J Luft; R Hafner; A H Korzun; C Leport; D Antoniskis; E M Bosler; D D Bourland; R Uttamchandani; J Fuhrer; J Jacobson
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

10.  Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy.

Authors:  R J Chinn; I D Wilkinson; M A Hall-Craggs; M N Paley; R F Miller; B E Kendall; S P Newman; M J Harrison
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

View more
  4 in total

1.  Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.

Authors:  Amr Amin; Hosna Moustafa; Ebaa Ahmed; Mohamed El-Toukhy
Journal:  J Neurooncol       Date:  2011-09-13       Impact factor: 4.130

Review 2.  Update on HIV lymphoma.

Authors:  Ariela Noy
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

Review 3.  Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: A systematic review and meta-analysis.

Authors:  Mo Yang; James Sun; Harrison X Bai; Yongguang Tao; Xiangqi Tang; Lisa J States; Zishu Zhang; Jianhua Zhou; Michael D Farwell; Paul Zhang; Bo Xiao; Li Yang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 4.  MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice.

Authors:  Mio Sakai; Masahiro Higashi; Takuya Fujiwara; Tomoko Uehira; Takuma Shirasaka; Katsuyuki Nakanishi; Nobuo Kashiwagi; Hisashi Tanaka; Hitoshi Terada; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2021-06-14       Impact factor: 2.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.